Science Current Events | Science News | Brightsurf.com
 

Cancer treatment: Therapeutic approach gives hope for the treatment of multiple myeloma

February 08, 2016

A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.

The study was lead be Dr. Jean Roy, a haematologist at the Maisonneuve-Rosemont Hospital and professor at the University of Montreal, between 2001 and 2010 with 92 newly diagnosed patients. Using an approach developed at Maisonneuve-Rosemont, consisting of an autograft to reduce tumour mass followed by a family allograft three to four months later to clean the bone marrow of myeloma cells with immune cells from a family donor (immunotherapy), the study resulted in a total cure rate of 41%, a record level using this strategy. Moreover, patients in complete remission six months after the allograft had a relapse-free survival rate of 60%. Overall, the autograft strategy followed by allograft resulted in relapse-free survival rates of 20-25% in the long term.

"In many hospitals, doctors have abandoned the use of allografts for multiple myeloma due to the risk of toxicity and relapse. Our results, on the other hand, have led us to offer the treatment to more patients, especially younger patients and those with poorer prognoses," said Dr. Roy.

The results of this research were published in the specialized journal Bone Marrow Transplantation.

Other encouraging data

Moreover, in the same study, the mortality rate associated with this treatment over ten years was 10%, an extremely low rate following a family donor allograft. And while 50% of patients experienced a relapse of their myeloma, the subsequent treatment showed marked efficacy: 50% of these patients were alive five years after the relapse.

Based on these results, a new study aiming to reduce rates of relapse and complications is currently underway at Maisonneuve-Rosemont Hospital, with still preliminary but very encouraging results.

###

The study was supported by the University of Montreal's William Brock Fund.

University of Montreal


Related Multiple Myeloma Current Events and Multiple Myeloma News Articles


Carnegie Mellon develops bio-mimicry method for preparing and labeling stem cells
Researchers led by Carnegie Mellon University Professor of Biological Sciences Chien Ho have developed a new method for preparing mesenchymal stem cells (MSCs) that not only leads to the production of more native stem cells, but also labels them with a FDA approved iron-oxide nanoparticle (Ferumoxytol).

Demand for radiotherapy will rise substantially over next 10 years
The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%), according to a new study published in Radiotherapy and Oncology.

Preliminary study: Antibody therapy reduces cancer stem cells in multiple myeloma
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.

Combination therapy may be better than radiotherapy alone to treat aggressive brain cancer
Radiotherapy effectively damages brain tumors but the cancer cells can repair themselves in order to live on. Now, researchers at Sidney Kimmel Cancer Center have tested a strategy that combines radiotherapy with a drug that shuts down the ability of tumor to mend themselves.

A new class of drug slows growth of castration-resistant prostate cancer cells
A first-in-class sphingosine kinase 2 inhibitor slowed the growth of castration-resistant prostate cancer cells, in part by inhibiting the enzyme dihydroceramide desaturase (DEGS), but did not kill them, according to the results of preclinical in vitro and in vivo studies published in the December 2015 issue of Molecular Cancer Therapeutics by researchers at the Medical University of South Carolina (MUSC) and others.

Three studies point to effectiveness of new therapies for multiple myeloma
In a trio of studies to be presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, investigators at Dana-Farber Cancer Institute will present the results of clinical trials showing that new drug combinations can significantly extend the time in which multiple myeloma is kept in check in patients with relapsed or treatment-resistant forms of the disease.

Multiple myeloma patient study shows promise for natural killer cells
A first-in-human Phase I study of multiple myeloma patients combined expanded cord blood-derived natural killer cells with transplantation of a patient's own stem cells and high-dose chemotherapy with little or none of the side effects seen with current treatments.

New vaccine strategy better protects high-risk cancer patients from flu
Yale Cancer Center researchers have developed a vaccine strategy that reduces the risk of flu infections in cancer patients at highest risk for influenza. The findings were presented Dec. 6 at the 57th annual meeting of the American Society of Hematology in Orlando, Florida.

Targeting protein homeostasis holds potential to treat solid tumors and blood cancers
The success of proteasome inhibitors such as VELCADE® (bortezomib) and Kyprolis® (carfilzomib) for the treatment of multiple myeloma has shown that protein homeostasis, which is how cells maintain a balance of protein synthesis and degradation, is a valid pathway for developing drugs to treat cancer.

Personalized drug screening on horizon for multiple myeloma patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
More Multiple Myeloma Current Events and Multiple Myeloma News Articles

Multiple Myeloma Patient Handbook: 2017 Edition

Multiple Myeloma Patient Handbook: 2017 Edition
by International Myeloma Foundation


One of the most daunting aspects of being diagnosed with myeloma is learning about an unfamiliar disease that is quite complicated. The IMF’s Patient Handbook provides an overview of myeloma, with a focus on getting the correct diagnosis, the tests you really need, initial treatment options, and supportive care and how to get it.

The Myeloma Survival Guide: Essential Advice for Patients and Their Loved Ones

The Myeloma Survival Guide: Essential Advice for Patients and Their Loved Ones
by Jim Tamkin MD FACP FACE (Author), Dave Visel (Author)


The definitive guide to living a longer, fuller life with myeloma The Myeloma Survival Guide makes sense of the difficult questions myeloma patients face, dealing with every aspect of life after diagnosis, from creating a wellness team to navigating treatment options to building a financial safety net. Jim Tamkin, MD, who lived with myeloma for 11 years, and Dave Visel share the insights they've gained as a doctor, patient, and caregiver, including: Everything you need to know about drugs and treatments, including stem cell transplants How to deal with the pain and side effects of chemotherapy, radiation, and surgery Insurance and tax benefits to save money and get you the care you deserve Take-charge tools you can use today to feel better tomorrow...

A Lucky Life Interrupted: A Memoir of Hope

A Lucky Life Interrupted: A Memoir of Hope
by Tom Brokaw (Author)


NEW YORK TIMES BESTSELLER • WITH A NEW PREFACE BY THE AUTHOR • A powerful memoir of a dramatic year spent battling cancer and reflecting on a long, happy, and lucky life—from the bestselling author of The Greatest Generation, whose iconic career in journalism has spanned more than fifty years

Tom Brokaw has led a fortunate life, with a strong marriage and family, many friends, and a brilliant journalism career culminating in his twenty-two years as anchor of the NBC Nightly News and as bestselling author. But in the summer of 2013, when back pain led him to the doctors at the Mayo Clinic, his run of good luck was interrupted. He received shocking news: He had multiple myeloma, a treatable but incurable blood cancer. Friends had always referred to Brokaw’s “lucky...

NCCN Guidelines for Patients®: Multiple Myeloma, Version 1.2016

NCCN Guidelines for Patients®: Multiple Myeloma, Version 1.2016
by National Comprehensive Cancer Network® (NCCN®) (Author)


[OFFICIAL CURRENT VERSION] From the medical leaders of 27 of the world's most renowned cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to multiple myeloma. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources about the diagnosis and treatment of multiple myeloma. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative handbook be your guide! Part 1 - Multiple myeloma basics: Explains how and where this type of cancer starts. Part 2 - Testing for myeloma: Describes the tests...

Multiple Myeloma Study Guide; Concise Information That Every Med Student, Physician, NP, and PA Should Know

Multiple Myeloma Study Guide; Concise Information That Every Med Student, Physician, NP, and PA Should Know
by Chart-MD


Just the facts are included in this book. Written by a board certified medical oncologist, this is the perfect text if you are looking for a quick review of the information you need to know about multiple myeloma. We won’t waste your time with this rapid access information. The Multiple myeloma Study Guide has distilled the key details down to the concise facts that you will understand and remember.

The Multiple Myeloma Study Guide is an ideal resource for medical students and anyone who wants to understand more about Multiple myeloma.

Sample Text:

Fact: In the United States, the lifetime risk of getting multiple myeloma is 1 in 161 (0.62%).

Fact: Urinary monoclonal protein elevations in multiple myeloma are more likely to be...

The Ultimate Marathon: My Journey With Multiple Myeloma Cancer

The Ultimate Marathon: My Journey With Multiple Myeloma Cancer
by Tim McNeill (Author)


Tim McNeill was diagnosed with stage four Multiple Myeloma in June of 2002. Mr. McNeill’s original prognosis gave him only months if not weeks to live. As treatments began his kidneys failed and within days he contracted an MRSA infection. During the early days it was also discovered that the advanced stage of the cancer had destroyed several of the vertebrae in his back. This is the story of his early years of recovery. It is a story of personal perseverance and unrelenting determination. It is also the story of a family support group whose sheer will helped defy the medical odds for Mr. McNeill’s recovery. Most importantly, however, this is the story of Tim’s ability to compartmentalize and focus on the day to day battle of his recovery. His drive to take on one...

100 Questions  &  Answers About Myeloma (100 Questions and Answers)

100 Questions & Answers About Myeloma (100 Questions and Answers)
by Asad Bashey (Author), Rafat Abonour (Author), James W. Huston (Author)


EMPOWER YOURSELF! Whether you’re a newly diagnosed myeloma patient, a survivor, or a friend or relative of either, this book offers help. The only text to provide the doctor’s and patient’s views, 100 Questions & Answers About Myeloma, Third Edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a hematologist-oncologist specializing in myeloma treatment, and featuring “insider” advice from an actual patient, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.

"I Have WHAT??? Multiple Myeloma? Waldenstrom's Macroglobulinemia? Amyloidosis? MGUS? Written by Those Who Know!!!"

"I Have WHAT??? Multiple Myeloma? Waldenstrom's Macroglobulinemia? Amyloidosis? MGUS? Written by Those Who Know!!!"
by Debra Berenson (Author)


The wife of well-known oncologist shares patients' candid cancer stories and also provides useful information from the doctors and other healthcare professionals who treat multiple myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and MGUS.

Multiple Myeloma: The Plain English Handbook for Patients and Care Givers

Multiple Myeloma: The Plain English Handbook for Patients and Care Givers
by Robert J. Heller (Author)


A comprehensive handbook and guide in easy to understand terms dealing with Multiple Myeloma; the disease, treatments, medications, lifestyle changes, and resources. Written by a non-medical author and based upon personal experiences. Updated annually.

Multiple Myeloma: Learn What Is Cause, Risk Factors, Symptoms, Diagnosis, Treatment and Health Care (Illustrated)

Multiple Myeloma: Learn What Is Cause, Risk Factors, Symptoms, Diagnosis, Treatment and Health Care (Illustrated)


Multiple Myeloma - Enhanced Edition: Learn What Is Cause, Risk Factors, Symptoms, Diagnosis, Treatment and Health Care (Annotated and Illustrated) provides you overall information about brain tumor. This book was written by Medical Professionals from National Cancer Institute with scientific details. You will learn the cause, risk factors, symptoms, treatments, etc that will helpful for both readers who are interesred in health and whoever have a member in family suffer from cancer. Moreover, this edition of the book includes;

- Eating Hints: Before, During, and After Cancer Treatment

- Follow-up Care After Cancer Treatment

- How To Find a Doctor or Treatment Facility If You Have Cancer

- Facing Forward: Life After Cancer Treatment

-...

© 2017 BrightSurf.com